Nadroparin and Apixaban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Nadroparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines are blood thinners. Apixaban (Eliquis) and nadroparin both work to slow blood clotting, just in slightly different ways. When you take them together, their effects add up, so your blood becomes thinner than it would be with either one alone. That means a higher chance of bleeding, which can sometimes be serious.
Watch for signs like unusual bruising, pink or red urine, black or bloody stools, nosebleeds that won't stop, or bleeding gums. If you notice heavy bleeding, get emergency help right away. The good news: sometimes doctors purposely use two blood thinners for a short time, and your care team can manage this safely by watching you closely and adjusting your plan.
Mechanism: Additive anticoagulation. Apixaban is a direct factor Xa inhibitor; nadroparin is a low-molecular-weight heparin acting largely through antithrombin-mediated anti-Xa activity. Combined use produces additive anti-Xa effect (neither is a prodrug). PD studies with apixaban plus enoxaparin showed a 50 to 60 percent increase in anti-Xa activity.
- Direction: Increased bleeding risk (additive PD effect).
- Evidence: Probable; Severity: major.
- Management: Avoid overlap unless clinically indicated. Discontinue apixaban with active pathological bleeding; effect persists at least 24 h post-dose. A specific reversal agent for anti-Xa activity is available; PCC, aPCC, or rFVIIa may be considered. During PCC use, PT/INR/aPTT and anti-Xa monitoring are not reliable. Counsel on bleeding signs.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Giving apixaban, a factor Xa inhibitor, together with another anticoagulant heightens the likelihood of bleeding. Pharmacodynamic drug interaction studies of apixaban showed that combining apixaban with enoxaparin produced a 50% to 60% rise in anti-factor Xa activity. If active pathological bleeding develops, apixaban should be stopped. There is an agent available that reverses apixaban's anti-factor Xa activity. Apixaban's pharmacodynamic effect can be anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled about the signs and symptoms of blood loss and instructed to report them without delay or to visit an emergency room. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered as options. When PCCs are administered, using a clotting test (PT, INR, or aPTT) or anti-factor Xa (FXa) activity to monitor apixaban's anticoagulation effect is not helpful and is not advised. Absorption of apixaban is decreased by activated oral charcoal, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both exactly as prescribed unless your care team tells you otherwise. Sometimes two blood thinners are used together on purpose for a short period, and your team can manage this.
- Your care team may monitor you more closely and individualize your treatment plan.
- Learn the signs of bleeding: unusual bruising, blood in urine or stool, black stools, prolonged nosebleeds, vomiting blood, severe headache, or dizziness.
- Report bleeding immediately or go to an emergency room. A reversal agent for apixaban's effect is available if needed.
- Do not start or stop either medicine on your own. Ask your pharmacist or prescriber before adding any new drug.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations examining pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was noted when apixaban and enoxaparin were given together 1.
Common questions
Can I take Nadroparin and Apixaban together?
Using apixaban and nadroparin together adds up their blood-thinning effects and raises your bleeding risk, so watch closely for any signs of bleeding and get emergency care if serious bleeding occurs. Take both only as your care team directs. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Nadroparin and Apixaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Nadroparin and Apixaban interaction managed?
Keep taking both exactly as prescribed unless your care team tells you otherwise. Sometimes two blood thinners are used together on purpose for a short period, and your team can manage this. Your care team may monitor you more closely and individualize your treatment plan. Learn the signs of bleeding: unusual bruising, blood in urine or stool, black stools, prolonged nosebleeds, vomiting blood, se… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Nadroparin or Apixaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Nadroparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist